Lifeward Ltd. (LFWD)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $6.10
- As of
Kresmion compiles this page from LFWD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Lifeward Ltd. (LFWD): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-08.
See the full LFWD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LFWD on one page. Preview it with sample data, then open it live with a free account.
Preview the LFWD dossierActive signals for LFWD
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 6.8%, EPS $-1.46 vs $-1.3668 estimate
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in LFWD
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in LFWD
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 86.4% - EPS $-6.96 vs $-3.7332 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 8.8% - EPS $-2.4 vs $-2.6316 estimate
FREE, NO ACCOUNT
Every signal on LFWD, as it fires
You are seeing 5 of 8 signals recorded on LFWD since 2026-05-17.
The five above landed across 4 days. The other 3 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in LFWD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP M8216Q309 · 2026Q2 | $142K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP M8216Q309 · 2026Q2 | $87K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, LFWD
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
LFWD against its peers
LFWD's operating margin of -1405.3% ranks in the 17th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | LFWD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.4M USD | 4.5M USD | 43 | 21 |
| Gross margin | 602.0% | 53.7% | 98 | 21 |
| Operating margin | -1405.3% | -247.2% | 17 | 20 |
| Net margin | -1422.4% | -171.6% | 15 | 22 |
| Return on equity | -236.8% | -137.2% | 28 | 22 |
| 1 year | -32.2% | -41.3% | 66 | 15 |
Peers (24): GTHP, HSCS, RDGL, MODD, PMI, PAVM, BDMD, SINT, PLSM, PETV, FOFA, NSPR, ALRTF, ITOC, IRIX, CTSO, NSYS, ELUT, CVRX, TNON, AEMD, ARAY, BMRA, QTI. Left out: NMTC (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (LFWD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow LFWD on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to LFWD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.